KS Biomedix Holdings is a company that develops pharmaceutical products and provide consulting services.

EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure—a minimally invasive solution that addresses a significant unmet clinical need. EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington.

Roussel UCLAF.

EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders. It is performing clinical trials to pursue FDA approval for a new treatment for sphincter-related disorders such as gastroesophageal reflux disease (GERD) and urinary urge incontinence. Its microstimulator technology provides long-term reflux control by restoring normal esophageal function that directly targets the patient's weak or dysfunctional lower esophageal sphincter (LES) muscle between the stomach and the esophagus and enable patients to reduce or avoid typical gastrointestinal side effects of traditional anti-reflux surgery.

Curon Medical, Inc. develops, manufactures and markets proprietary products for the treatment of gastrointestinal disorders. Its products consist of radiofrequency generators and single-use disposable devices. The company was founded on May 1, 1997 and is headquartered in Fremont, CA.

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Cousin Biotech is a medical company that designs and manufactures soft and textile implantable medical devices for visceral, spine, uro-gynaecology, and obesity surgery. Aside from manufacturing of its own brand products, Cousin Biotech has developed a subcontracting department: the Northern France company offers its know-how and develops tailored-made solutions for the main actors of the international market of implantable medical devices. The company was founded in 1994 as a Cousin Frères subsidiary. Its headquarters is located in Wervicq-Sud, France.

Knorr-Bremse GmbH manufactures braking systems and sub-systems for rail and commercial vehicles. It offers magnetic track and eddy current breaks, flange devices, windscreen wiper and washing systems, sanding systems, and brake test units. The company was founded by Georg Knorr in 1905 and is headquartered in Mödling, Austria.

Sentinel Group LLC provides emergency and environmental property restoration services. It specializes in emergency response, mitigation and reconstruction of properties damaged by wind, water, fire, mold, and environmental and other types of disasters for customers primarily in New York, New Jersey and Connecticut. The company was founded in 2015 and is headquartered in Ardsley, NY.

Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi. It was the second largest French pharmaceutical company before it was acquired by Hoechst AG of Frankfurt, Germany in 1997, with pharmaceutical operations combined into the Hoechst Marion Roussel (HMR) division in the United States. Roussel Uclaf's agrochemical operations had been transferred to Hoechst Schering AgrEvo GmbH in 1994.

Medical device company focused on innovative endoscopic procedures and devices. Medigus developed an entire endoscopic system for intraluminal treatment of GERD (Gastroesophageal Reflux Disease), one of the most common chronic diseases in the Western world. The endoscopic system for the treatment of GERD - the SRS - combines a miniaturized video camera, a surgical stapler and ultrasonic sights for alignment in a single instrument. The SRS system and its unique flexible endoscope allows gastroenterologists and surgeons to perform endoluminally a true partial anterior fundoplication, thereby revolutionizing the treatment of GERD by eliminating the need for open or laparoscopic surgery - the current standard practice for treating severe GERD. Shifting the GERD treatment from surgery to an endoluminal procedure, without opening the abdominal cavity, is a REVOLUTION. In addition, Medigus designs and manufactures endoscopy systems for partner companies based on its proprietary technologies, which include all necessary elements for performing a wide range of endoscopic procedures such as the world’s smallest video cameras, respective video processors and endoscopy suits, and various types of rigid, semi-flexible and flexible disposable video endoscopes.

Synecor evolved from the confluence of several synergistic strategic relationships, initially in the field of interventional cardiology, but has expanded its field to include all medical specialties such as obesity, spine therapeutics, and more. Synecor was founded by Dr. Richard Stack after two decades of collaboration with leading cardiologists, clinician-inventors, and scientists from across the nation and as an outgrowth of close working relationships among corporate leaders in the medical device industry, and experts at Duke University. Mr. William Starling, a well-known Silicon Valley medical device entrepreneur/executive with a successful 27-year career in the high technology cardiovascular device industry, partnered with Dr. Stack to co-manage Synecor and form strategic relationships with leading venture capital partnerships (Delphi Ventures and Frazier & Company) and a leading investment bank (Deutsche Banc Alex. Brown). To complete the partner team, Dr. Stack and Mr. Starling also partnered with major life sciences corporations with vast resources and knowledge (Guidant and GE Medical Systems).

Xlumena develops image-guided therapeutic endoscopy products. It develops Bile Duct Stenting, a self-expanding anchor stent and precision XL delivery system. The company also develops Pseudocyst Drainage, an integrated XF system designed to enable reliable pseudocyst drainage; and Hiatal Hernia Repair that enables the repair of a hiatal hernia from inside the GI lumen. Xlumena was founded in 2007 and is based in Mountain View, California.

Yantai Ruizhi Biomedical Technology Co., Ltd., established on 2014-03-24, Business scope includes biomedical technology research and development,Transfer and Technology Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Microval SAS is a private company headquartered in Saint-Just-Malmont, France, that manufactures medical, surgical and dental equipment. It was founded in 1994.